Rudolf, Gabrielle
Lesca, Gaetan
Mehrjouy, Mana M
Labalme, Audrey
Salmi, Manal
Bache, Iben
Bruneau, Nadine
Pendziwiat, Manuela
Fluss, Joel
de Bellescize, Julitta
Scholly, Julia
Møller, Rikke S
Craiu, Dana
Tommerup, Niels
Valenti-Hirsch, Maria Paola
Schluth-Bolard, Caroline
Sloan-Béna, Frédérique
Helbig, Katherine L
Weckhuysen, Sarah
Edery, Patrick
Coulbaut, Safia
Abbas, Mohamed
Scheffer, Ingrid E
Tang, Sha
Myers, Candace T
Stamberger, Hannah
Carvill, Gemma L
Shinde, Deepali N
Mefford, Heather C
Neagu, Elena
Huether, Robert
Lu, Hsiao-Mei
Dica, Alice
Cohen, Julie S
Iliescu, Catrinel
Pomeran, Cristina
Rubenstein, James
Helbig, Ingo
Sanlaville, Damien
Hirsch, Edouard
Szepetowski, Pierre
Article History
Received: 17 September 2015
Revised: 1 May 2016
Accepted: 20 May 2016
First Online: 29 June 2016
Competing interests
: Dr N Tommerup receives funding from the University of Copenhagen (UCPH), Lundbeck Foundation, and The Danish Council for Independent Research – Medical Sciences. Dr KL Helbig, Dr S Tang, Dr DN Shinde, Dr R Huether, and Dr HM Lu are employed by and receives a salary from Ambry Genetics. Exome sequencing is among its commercially available tests. Dr S Coulbaut and Dr M Abbas are UCB Pharma employees. Dr Scheffer reports grants from NHMRC and NIH during the conduct of the study: Annals of Neurology, Epileptic Disorders, and Neurology; personal fees from UCB, Athena Diagnostics, Transgenomics, and GlaxoSmithKline, outside the submitted work; in addition, Dr Scheffer has a patent A Diagnostic Method for Epilepsy with royalties paid. Hannah Stamberger is PhD fellow of the Fund for Scientific Research Flanders. Dr Heather Mefford receives funding from the National Institutes of Health. Dr Ingo Helbig is supported by intramural funds of the University of Kiel, by a grant from the German Research Foundation (HE5415/3-1) within the EuroEPINOMICS framework of the European Science Foundation and grants of the German Research Foundation (DFG, HE5415/5-1, HE 5415/6-1), German Ministry for Education and Research (01DH12033, MAR 10/012), and German chapter of the International League against Epilepsy (DGfE). He is also supported by the Children’s Hospital of Philadelphia (CHOP) with the Genomics Research Initiative Network (GRIN). Dr Szepetowski reports grants from French National Research Agency (ANR), UCB-Pharma France, and European Union FP7 during the conduct of the study. All the other authors declare no conflict of interest.